AGT and Cognitive impairment: The anti-Alzheimer’s effect of telmisartan was demonstrated in an ovariectomized hyperglycaemic rat model, causing decreased expression of Ang I and II receptors in the hippocampus, improving cognitive impairment and reducing A-β and τ protein levels [85].